Adaptation and validation of the chronic disease helplessness survey for Chinese patients with chronic conditions Authors: Bingying Huang, Jiaying Tang, Zhiting Guo, Ying Chen, Lili Zhou, Fengying Zhang, Qiaomei Zhao, Hua Zhao Published: 2026 ABSTRACT AbstractBackgroundPatients with chronic diseases often experience learned helplessness (LH), which affects their psychological state and triggers physical symptoms, seriously affecting their quality of life. The Chronic Disease Helplessness Survey (CDHS) was developed to measure LH in patients with chronic diseases, but it has not been validated in the Chinese population. The aim of this study was to translate the CDHS into Chinese and validate its reliability and validity in Chinese patients with chronic diseases, thus providing an appropriate assessment tool for the Chinese population.MethodsA forward-backward English-Chinese-English translation of the CDHS was performed according to standard practice. This study recruited 106 chronic disease patients from March to May 2024, and 100 cases in September 2025. The Chinese CDHS has 12 items in three dimensions: cognitive, motor, and emotional. The criterion-related tools used included the Learned Helplessness Scale-18 (LHS-18), the Generalized Anxiety Disorder Scale (GAD-7), the Patient Health Questionnaire-9 (PHQ-9), and the Self-Efficacy for Managing Chronic Disease 6-Item Scale (SEMCD). Criterion-related validity was assessed by examining the correlations between CDHS scores and the scores of these tools. The internal consistency was tested via Cronbach’s α, the test-retest reliability was tested via the intraclass correlation coefficient (ICC), and the construct validity was tested via Exploratory Factor Analysis and Confirmatory Factor Analysis.ResultsThe Chinese CDHS had a Cronbach’s α of 0.896, indicating good internal consistency, and an ICC of 0.929, indicating high stability. EFA and CFA showed a good fit for the three-factor model (χ2/df = 1.623, CFI = 0.961, TLI = 0.949, NFI = 0.905, RMSEA = 0.078). CDHS scores were positively correlated with LHS-18 (r = 0.659, P < 0.001), GAD-7 (r = 0.659, P < 0.001), and PHQ-9 (r = 0.714, P < 0.001) scores and negatively correlated with SEMCD scores (r = -0.614, P < 0.001), demonstrating good criterion-related validity.ConclusionThe Chinese CDHS has good reliability and validity for assessing learned helplessness in Chinese chronic disease patients and is a valuable tool for early psychological intervention, it could be used in screening, clinical decision-making, or monitoring psychological states over time.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12888-026-08260-1.Keywords: Chronic disease, Learned helplessness, CDHS, Reliability, Validity Introduction In the long-term management of chronic diseases, patients may experience recurrent disease episodes, treatment challenges, and frequent contact with the healthcare system. Such experiences can give rise to a pervasive sense of helplessness among patients, as evidenced by studies of those with cancer [1], systemic lupus erythematosus [2], rheumatoid arthritis [3], chronic obstructive pulmonary disease [4], and end-stage renal disease [5]. The concept of learned helplessness (LH) was initially proposed by Seligman [6], who defined it as a series of cognitive, emotional, and behavioral deficits that individuals may develop after repeatedly encountering uncontrollable negative events. LH not only affects the psychological state of chronic disease patients but also triggers a series of physical symptoms (e.g., pain, feeling tired/having low energy, dizziness), which have a significant impact on overall quality of life [7–9]. Moreover, there is a positive correlation between helplessness and social isolation [10], anxiety [11], depression [12–14], and even suicidal behavior [15]. Furthermore, helplessness may impair an individual’s capacity to engage in self-care and treatment adherence, thereby increasing the risk of a poor prognosis [14, 16]. Notably, patients’ self-efficacy may serve to mitigate their sense of helplessness [14, 16]. The current array of tools for assessing LH is diverse but not without its limitations. The most commonly utilized instruments are the Learned Helplessness Scale-20 [17] and Learned Helplessness Scale-18 [18], which were mainly used to assess helplessness in normal people. And instruments such as the Arthritis Helplessness Index (AHI) [19] was designed for arthritis patients, and the COPD Helplessness Index (CHI) [4] was designed for those with COPD patients. Although these tools are effective, their scope is limited, as they are designed to assess specific diseases and do not provide a comprehensive assessment for all patients with chronic diseases. In contrast, the Chronic Disease Helplessness Survey (CDHS), developed and validated by Yessick et al. [20], is designed to assess learned helplessness in patients with any chronic disease. The CDHS comprises 12 items distributed across three dimensions (cognitive, motor, and emotional) and has been rigorously validated for reliability and validity in American chronic disease populations, with Cronbach’s α coefficients of 0.812 (cognitive), 0.909 (motor), and 0.762 (emotional), indicating high internal consistency. The results of the confirmatory factor analysis indicated an acceptable fit for the three-factor model, with the following fit indices: RMSEA = 0.081, SRMR = 0.064, and CFI = 0.95. Furthermore, research has demonstrated a notable correlation between helplessness and heightened pain intensity and diminished self-efficacy. A significant advantage of the CDHS is its alignment with the foundational theory of learned helplessness, capturing not only controllability but also the full spectrum of deficits identified by Maier and Seligman: cognitive, emotional, and motivational/motor. As we all know, chronic disease patients may tend to attribute disease-related hardships to stable, internal, or global causes, and this bias reinforces feelings of helplessness, erodes confidence in self-management And due to the expectation that their actions will not improve outcomes patients may reduce engagement in adaptive behaviors. The uncontrollable stress of living with a chronic condition often triggers persistent negative emotions. This is crucial for obtaining a nuanced understanding of LH in the context of chronic diseases. Nevertheless, there is currently no specific tool for assessing LH in Chinese patients with chronic diseases. Accordingly, the objective of this study was to translate the CDHS into Chinese and to validate its reliability and validity among Chinese patients with chronic diseases. This study will help healthcare providers assess the psychological state of patients with chronic diseases, identify those with high levels of learned helplessness, and provide targeted psychological interventions. Specifically, we used Cronbach’s α coefficient to assess internal consistency and intraclass correlation coefficient (ICC) to assess test-retest reliability. Structural validity was assessed using exploratory factor analysis (EFA) and confirmatory factor analysis (CFA). In accordance with previous research [18, 21–23], the LHS-18, the Generalized Anxiety Disorder 7-item scale (GAD-7), the Patient Health Questionnaire-9 (PHQ-9), and the Self-Efficacy for Managing Chronic Disease 6-item scale were used to examine criterion validity. We hypothesized that the Chinese version of the CDHS would have the following characteristics among Chinese patients with chronic diseases: (1) good internal consistency and test-retest reliability; (2) validation of the three-factor structure; and (3) significant positive correlations of CDHS total and dimension scores with LHS-18, GAD-7, and PHQ-9 scores and significant negative correlations with Self-Efficacy for Managing Chronic Disease scores, indicating good criterion validity. Methods Translation procedure Written permission for the translation and use of the Chronic Disease Helplessness Survey (CDHS) was obtained from the original developer prior to conducting the study. All translation and back-translation procedures were conducted in consultation with the original developer to ensure fidelity and conceptual equivalence. Forward translation: two independent translations of the English version of the scale into Chinese were conducted by a master’s degree holder in nursing with over one year of study experience in an English-speaking country and a clinical expert in chronic disease management who holds a PhD in nursing, is a native Chinese speaker, and has been a visiting scholar at Johns Hopkins University. The research team compared the two versions (A1 and A2) and, through discussion, selected the most appropriate expressions to form the preliminary translated version A. Back-translation: two independent back-translations of version A into English were conducted by an English language teacher with a master’s degree in English who has resided in an English-speaking country for an extended period and a clinical physician specializing in chronic disease management who holds a PhD and is an associate chief physician. The research team then proceeded to compare the back-translated versions (B1 and B2) and, following discussion and modification, formed the preliminary back-translated version B. Expert review: According to the cross-cultural debugging criteria proposed by Beaton et al. [24]., an internationally accepted scale localization guide, this study recruited three bilingual experts who are familiar with chronic diseases or psychology and whose native language is Chinese to form an expert review panel through purposive sampling, and evaluated the instructions and response formats of the Chinese version of CDHS. They primarily adjusted the translated scale for linguistic equivalence (refining ambiguous expressions to align with colloquial Chinese), cultural equivalence (adapting culture-specific examples), and conceptual equivalence (ensuring core constructs matched the original scale), with details on key revisions The final Chinese version, designated Version C, was developed through a process of discussion and modification in consultation with the original author via email. Cross-cultural adaptation A preliminary survey was conducted with 18 patients diagnosed with chronic diseases to assess the layout and comprehensibility of the scale items. Participants were interviewed cognitively through observation and verbal inquiry to assess their understanding and response processes to the Chinese version of CDHS. The feedback obtained from this survey was instrumental in the development of the definitive Chinese version of the CDHS. The scale was translated with great care to align with the Chinese cultural and linguistic context. This was achieved through cognitive debriefing interviews with Chinese participants. The interviews identified and addressed potential misunderstandings or cultural discrepancies, thereby ensuring the scale’s relevance and clarity for the Chinese population. The objective of this revision is to provide a more concise and systematic account of the translation and back-translation process, as well as the cross-cultural adaptation. It aims to highlight the qualifications of the individuals involved and the methodical approach taken to ensure the scale’s suitability for the Chinese context. Participants and research procedures for field test A convenience sampling method was used to recruit 106 chronic disease patients from the Second Affiliated Hospital of Zhejiang University between March and May 2024, and 100 chronic disease patients in September 2025. Finally, a total of 206 patients with chronic diseases were included in this study. The inclusion criteria for participants were as follows: were aged 18 years or older, had been diagnosed with one or more chronic diseases as defined by the World Health Organization (WHO), demonstrated clear consciousness and ability, and provided voluntary informed consent. Individuals with a history of mental illness, consciousness disorders, or concurrent severe, life-threatening diseases were excluded from participation. The questionnaire results from the 206 recruited patients were conducted for exploratory factor analysis (EFA) and confirmatory factor analysis (CFA). To ensure reliable factor analysis, it is advisable to recruit a minimum of 120 participants for this study, in accordance with the guideline of at least 10 participants per item in EFA. Considering a potential 10–20% attrition rate, the target sample size was adjusted to 135 to 150 participants. Once all the requisite preparations had been completed, data collection commenced with the distribution of questionnaires to participants. The Chinese version of the Chronic Disease Helplessness Survey Scale was completed by patients independently and anonymously, with the option of contacting the research team for any queries. Furthermore, 10 patients consented to a retest after two weeks while maintaining consistent chronic disease management strategies. Research tools General demographic information questionnaire This study assessed the following demographic information based on preliminary survey data and literature [25]: age, sex, religion, body mass index (BMI), place of residence, educational level, employment status, marital status, number of children, average monthly household income (RMB), medical insurance type, hospitalized due to illness, number of medication types, long-term pain management, and chronic diseases type. The chronic disease helplessness survey scale The Chronic Disease Helplessness Survey Scale was developed by Lindsey R. Yessick [20] and has been demonstrated to be an efficacious instrument for evaluating helplessness in patients with chronic diseases. The questionnaire comprises twelve items, which are rated by the subject. Each item describes a typical symptom of helplessness and is scored based on the frequency of this symptom over a certain period. The scoring system assigns one point to responses indicating “not at all,” two points to responses indicating “rarely,” three points to responses indicating “sometimes,” four points to responses indicating “mostly,” and five points to responses indicating “completely.” The scale employs a five-point Likert scoring method, with total scores ranging from 12 to 60. Higher scores on the scale indicate a greater sense of helplessness. The reliability and validity of this scale have not been tested in the Chinese chronic disease population. In this study, the Cronbach’s α coefficient for the total CDHS was 0.896, with 0.885 for the cognitive dimension, 0.906 for the motor dimension, and 0.868 for the emotional dimension. Criterion-related validity scale To evaluate criterion validity, this study employed the Learned Helplessness Scale-18 (LHS-18), Generalized Anxiety Disorder Scale (GAD-7), Patient Health Questionnaire-9 (PHQ-9), and Self-efficacy for Managing Chronic Disease 6-Item Scale (SEMCD-6). The Learned Helplessness Scale-18 (LHS-18) is a psychometric instrument designed to assess the degree to which an individual has learned to accept helplessness as a personal attribute. The LHS-18 was developed by the Chinese scholar Wu Xiaoyan [18] and comprises two dimensions, namely, helplessness (13 items) and despair (5 items), resulting in a total of 18 items. The scale is evaluated using a five-point Likert scale, with each item scored from “not at all” (1) to “completely” (5), resulting in a total score range of 18–90. Higher scores indicate greater helplessness. In this study, the Cronbach’s α coefficient for the total scale was 0.970, with 0.967 for the helplessness dimension and 0.872 for the despair dimension, indicating good reliability. This scale was used in this study with permission from the original author. The Generalized Anxiety Disorder Scale (GAD-7) is a self-report instrument designed to assess the severity of generalized anxiety disorder (GAD) symptoms. The GAD-7 was developed by Spitzer et al. [26] and has been demonstrated to be an effective tool for screening for GAD and assessing its severity. The self-rating tool comprises seven items, each describing a typical GAD symptom. It is evaluated using a four-point Likert scale based on the frequency of symptoms over the past two weeks. The response options were “not at all” (0), “several days” (1), “more than half the days” (2), and “nearly every day” (3). In 2010, He et al. translated the GAD-7 into Chinese and validated it among general hospital outpatients. In this study, the Cronbach’s α coefficient for the total scale was 0.943. The Patient Health Questionnaire-9 (PHQ-9) is a self-report instrument designed to assess the severity of depressive symptoms over the past two weeks. The PHQ-9 was developed by Kroenke et al. [27] in 2001, based on the DSM-IV criteria for major depressive disorder, with the objective of evaluating the symptoms experienced by patients over the past two weeks. The PHQ-9 comprises nine items, each of which is evaluated using a four-point Likert scale with responses ranging from “not at all” (0) to “nearly every day” (3). The total score ranges from 0 to 27, with higher scores indicating a greater likelihood of depression. Higher scores on the PHQ-9 indicate a greater likelihood of depression. In this study, the Cronbach’s α coefficient for the total scale was 0.931. The Self-Efficacy for Managing Chronic Disease 6-Item Scale (SEMCD) is a psychometric instrument designed to assess an individual’s confidence in his or her ability to manage chronic disease. The scale was developed by Lorig et al. [23] in 2001 and consists of six items divided into two dimensions. The scale comprises two dimensions: “self-efficacy for managing symptoms” (confidence in managing symptoms such as low mood, pain, and fatigue) and “self-efficacy for managing common disease aspects.” The scale employs a visual analog scale, with scores ranging from 1 (no confidence at all) to 10 (total confidence). The total score is derived from the average of the item scores. In this study, the Cronbach’s α coefficient for the scale was 0.905, indicating a high degree of internal consistency. Ethical considerations This study was conducted in accordance with the tenets of the Declaration of Helsinki and in strict adherence to the relevant national laws. All participants provided informed consent. The study was approved by the Institutional Review Board of the hospital (Approval No. 2023 − 0664). The confidentiality of the data was maintained throughout the survey period. Data analysis Data analysis was conducted using SPSS 24.0 and Amos 28.0 software. Categorical data are summarized as percentages, and continuous data are summarized as the mean (SD). And in our study, no significant missing data were found. A p-value of less than 0.05 was considered to indicate statistical significance, and a two-sided test was utilized. Since the questionnaire items are measured as ordinal data, but considering the psychometric characteristics of the scale and the consistency with the verification procedures of the original questionnaire, we still treat them as interval-scaled in the main analysis. The internal consistency of the scale was evaluated using the Cronbach’s alpha coefficient. To assess the test-retest reliability of the instrument, the intraclass correlation coefficient (ICC) was employed. Pearson correlation analysis was also employed to investigate the interrelationships between CDHS scores and those from the criterion-related scales (LHS-18, GAD-7, PHQ-9, and SEMCD-6). For evaluating the instrument’s construct validity, the data was divided into two halves, one for Exploratory Factor Analysis (EFA) and the other for Confirmatory Factor Analysis (CFA). Principal component analysis extraction and varimax orthogonal rotation were used to conduct EFA. Amos 31.0 software was used to construct a measurement model of latent variables and manifest variablesin accordance with the scores of three common factors and each item. To assess the fit of the CFA model, .these several indices including Chi-square divided by degrees of freedom (χ2/df), normed Fit Index (NFI), comparative fit index (CFI), Tucker‒Lewis index (TLI), and root mean square error of approximation (RMSEA) were evaluated. Results Participants A total of 206 patients with chronic diseases were included in the study. The mean age of the participants was 40.26 (9.41) years, with 56.80% identifying as female. The mean body mass index (BMI) was 21.78 (3.64). Among the participants, 51.94% had a college education or higher, 66.99% lived in urban areas, 42.23% were employed, 44.63% were unmarried. Regarding monthly household income, 22.33% of respondents earned less than 4,000 RMB, 39.81% earned between 4,001 and 7,000 RMB, and 37.86% earned more than 7,000 RMB. Furthermore, 62.62% of the participants had medical insurance, 68.93% had been hospitalized due to their illness, 35.44% were taking three or more medications, and 31.55% had long-term pain management. The diseases of the participants included rheumatic immune diseases (36.89%), circulation system disease (11.65%), digestive system diseases (11.17%), respiratory disease (13.59%), and metabolic diseases (14.56%), and neurological, oncological, and orthopedic diseases (12.14%) (Table 1 provides further details). Table 1Social and demographic information of the participants (n = 206)VariablesMean(SD)/ n(%)Age, year40.26(9.41)Female sex, n (%)117(56.80%)BMI, Kg/m221.78(3.64)Education level, n (%)Primary school or below30(14.56%)Middle school44(21.36%)High school25(12.14%)Technical college47(22.82%)University and above60(29.13%)Residence, n (%)Urban138(66.99%)Rural68(33.01%)Study or Work Status, n (%)Employed87(42.23%)Unemployed or not working73(35.44%)Retired20(9.71%)Student26(12.62%)Marital status, n (%)Single62(30.10%)Married114(55.34%)Divorced30(14.56%)Average monthly household income (RMB), n (%)< 400046(22.33%)4001 ~ 700082(39.81%)> 700078(37.86%)Medical insurance, n (%)Self-funded57(27.67%)Medical insurance129(62.62%)Commercial insurance14(6.80%)Combined medical and commercial insurance6(2.91%)Hospitalized due to illness, n (%)Yes142(68.93%)No64(31.07%)Number of Medication Types, n (%)013(6.31%)1 ~ 3120(58.25%)4 ~ 659(28.64%)> 614(6.80%)Long-term pain management, n (%)Yes65(31.55%)No141(68.45%)Type of chronic diseases, n (%)Rheumatic immune diseases76(36.89%)Circulation system disease24(11.65%)Digestive system diseases23(11.17%)Respiratory disease28(13.59%)Metabolic diseases30(14.56%)Others (e.g., neurological, oncological, orthopedic)25(12.14%) Social and demographic information of the participants (n = 206) Reliability analysis Internal consistency The revised Chinese version of the CDHS demonstrated a Cronbach’s α coefficient of 0.896. The Cronbach’s α coefficients for the cognitive, motor, and emotional dimensions were 0.885, 0.906, and 0.868, respectively. The correlations between each item and the total score, as well as the scores for each dimension, are showed in Supplementary Table 1. The range of Cronbach’s α coefficients after deleting any single item was 0.880–0.897 (see Supplementary Table 1). Significant correlations were observed between each item and the total score, as well as the corresponding dimension scores, with correlation coefficients ranging from 0.401 to 0.926. Item 12 was reverse scored. Furthermore, significant correlations were found between the scores of the three dimensions and the total score, with correlation coefficients ranging from 0.229 to 0.913. The detailed correlation coefficients are provided in Supplementary Table 2. Test-retest reliability The study subjects were surveyed again after two weeks, and the reproducibility of the Chinese version of CDHS was verified through reliability assessment of the first and second questionnaire results. Among 206 participants, 10 completed the questionnaire again after two weeks. The test-retest reliability of the Chinese version of the CDHS was demonstrated by an ICC of 0.929 (95% CI: 0.742–0.982) for the total score, 0.960 (95% CI: 0.849–0.990) for the cognitive dimension, 0.895 (95% CI: 0.634–0.973) for the motor dimension, and 0.794 (95% CI: 0.367–0.944) for the emotional dimension. The p values for all four ICCs were less than 0.05, indicating the high test-retest reliability of the scale. Validity analysis Exploratory factor analysis (EFA) Bartlett’s test of sphericity yielded a statistically significant result (χ²=851.311, P < 0.001), and the KMO measure of sampling adequacy exceeded 0.6 (KMO = 0.849), indicating that the Chinese version of the CDHS scale was suitable for factor analysis. The EFA analysis showed that the scale contained three factors, and the cumulative variance contribution rate of the three factors was 75.40%. Factor 1 (Cognitive), which comprises items 1, 2, and 3, accounted for 20.65% of the variance, while Factor 2 (Motor), which comprises items 4, 5, 6, 7, 8, and 9, explained 34.54% of the variance. Factor 3 (Emotional), which included items 10, 11, and 12, accounted for 20.70% of the total variance, and Fig. 1 indicated thethe scree plot agreed with the structure of the three factors. All items exhibited robust factor loadings on their respective factors, as illustrated in Table 2. These factors align with the original dimensions of the CDHS, indicating that the translated version maintains the structural integrity of the original scale. The scree plot of the CDHS in China. Eigenvalues are plotted to show the scree point. This scree plot shows the eigenvalues of the factors in the exploratory factor analysis (EFA), indicating a three-factor solution for the Chinese version of the Chronic Disease Helplessness Survey (CDHS) Table 2Factor loadings for items of the initial exploratory factor analysis(n = 103)CDHS-CCDHS-MCDHS-EItme10.8070.2250.072Itme2 0.920 0.1220.099Itme3 0.896 0.1130.115Itme40.111 0.678 0.194Itme50.158 0.855 0.174Itme60.170 0.805 0.178Itme70.081 0.877 0.231Itme80.205 0.762 0.321Itme90.121 0.752 0.377Itme100.0880.396 0.840 Itme110.0210.349 0.831 Itme120.2010.179 0.813 Factor loadings for items of the initial exploratory factor analysis(n = 103) Confirmatory factor analysis (CFA) The model offered by the CFA fit well with the data. The ratio of chisquare to degrees of freedom (χ²/df) = 1.623, root mean square error ofapproximation (RMSEA) = 0.078, comparative fit index (CFI) = 0.961, normed fix index (NFI) = 0.905, and Tucker-Lewis Index (TLI) = 0.949, all indicated the measurement model and the observed data had good fit (see Table 3). The measurement model of the Chinese CDHS is shown in Fig. 2. Standardized three-factor model of the Chinese version of the Chronic Disease Helplessness Survey (CDHS). Values represent standardized factor loadings and latent-variable correlations. Table 3CFA model goodness-of-fit indices (n = 103)CFA Modelsχ2/dfCFITLINFIRMSEAModel1.6230.9610.9490.9050.078Notes: χ2/df: A rating of 2 signifies an exemplary fit; scores between 2 and 3 indicate a solid fit; and ratings from 3 to 5 are conditionally acceptable; CFI (Comparative Fit Index): Ranges from 0 to 1, with values closer to 1 indicating a better fit, and a CFI above 0.9 is considered good; TLI (Tucker–Lewis Index): Ranges from 0 to 1, with values closer to 1 indicating a greater fit. A TLI above 0.95 is ideal; a TLI below 0.9 suggests respecification; NFI: A rating of 0.95 or above signifies an exemplary fit; scores between 0.9 and 0.95 indicate a solid fit; and ratings from 0.8 to 0.9 are conditionally acceptable; RMSEA (Root Mean Square Error of Approximation): ≤ 0.05 indicates high fit, and 0.05–0.08 indicates reasonable fit CFA model goodness-of-fit indices (n = 103) Notes: χ2/df: A rating of 2 signifies an exemplary fit; scores between 2 and 3 indicate a solid fit; and ratings from 3 to 5 are conditionally acceptable; CFI (Comparative Fit Index): Ranges from 0 to 1, with values closer to 1 indicating a better fit, and a CFI above 0.9 is considered good; TLI (Tucker–Lewis Index): Ranges from 0 to 1, with values closer to 1 indicating a greater fit. A TLI above 0.95 is ideal; a TLI below 0.9 suggests respecification; NFI: A rating of 0.95 or above signifies an exemplary fit; scores between 0.9 and 0.95 indicate a solid fit; and ratings from 0.8 to 0.9 are conditionally acceptable; RMSEA (Root Mean Square Error of Approximation): ≤ 0.05 indicates high fit, and 0.05–0.08 indicates reasonable fit Measurement model of the CDHS. The three-factor model of the CDHS, developed through confirmatory factor analysis (CFA), showed a good fit (χ2/df = 1.623, CFI = 0.961, TLI = 0.949, NFI = 0.905, RMSEA = 0.078) Criterion-related validity In accordance with previous related studies [28–31], the Chinese versions of the LHS-18, GAD-7, PHQ-9, and SEMCD-6 were used to assess criterion validity. Significant correlations were found between the total and dimension scores of the CDHS and the total and dimension scores of the other scales (ranging from 0.154 to 0.990), as detailed in Table 4. The total CDHS was found to be significantly positively correlated with the total LHS-18 score (r = 0.659, P < 0.001), the total GAD-7 score (r = 0.659, P < 0.001), and the total PHQ-9 score (r = 0.714, P < 0.001). Conversely, the total CDHS was significantly negatively correlated with the total SEMCD-6 score (r = -0.614, P < 0.001). Additionally, significant correlations were also observed between the dimension scores of the CDHS and the scores of the criterion-related scales. Table 4Criterion-related validity results (n = 206)CDHSCDHS-CCDHS-MCDHS-ELHS-18LHS18-HLHS18-DGAD-7PHQ-9SEMCD-6CDHS1.000CDHS-C0.586***1.000CDHS-M0.921***0.312**1.000CDHS-E0.819***0.229**0.608**1.000LHS-180.659**0.162*0.682**0.575**1.000LHS18-H0.653**0.154*0.679**0.571**0.990**1.000LHS18-D0.609**0.167*0.623**0.528**0.929**0.868**1.000GAD-70.659**0.178*0.654**0.611**0.740**0.749**0.646**1.000PHQ-90.714**0.204**0.752**0.572**0.847**0.831**0.808**0.841**1.000SEMCD-6-0.614**-0.289**-0.560***-0.544**-0.524**-0.513**-0.503**-0.473**-0.511**1.000Notes: *P < 0.05; **P < 0.01; CDHS=chronic disease helplessness survey, CDHS-C=cognitive dimension (Dimension 1), CDHS-M=motor dimension (Dimension 2), CDHS-E=emotional dimension (Dimension 3); LHS-18 = Chinese version of the Learned Helplessness Scale (18 items), LHS18-H=Helplessness Dimension, LHS18-D=Despair Dimension; GAD-7 = generalized anxiety disorder; PHQ-9 = Patient Health Questionnaire; SEMCD-6 = Self-efficacy for Managing Chronic Disease 6-Item Scale Criterion-related validity results (n = 206) Notes: *P < 0.05; **P < 0.01; CDHS=chronic disease helplessness survey, CDHS-C=cognitive dimension (Dimension 1), CDHS-M=motor dimension (Dimension 2), CDHS-E=emotional dimension (Dimension 3); LHS-18 = Chinese version of the Learned Helplessness Scale (18 items), LHS18-H=Helplessness Dimension, LHS18-D=Despair Dimension; GAD-7 = generalized anxiety disorder; PHQ-9 = Patient Health Questionnaire; SEMCD-6 = Self-efficacy for Managing Chronic Disease 6-Item Scale Discussion This study represents the translation and validation of the CDHS in a Chinese population with chronic diseases. The results demonstrate that the Chinese version of the CDHS exhibits satisfactory internal consistency and test-retest reliability. The EFA and CFA results indicated that the three-factor model exhibited good structural validity, with the bifactor model being the optimal fit. Significant correlations were observed between the CDHS scores and those of the criterion-related scales. These findings confirm that the Chinese version of the CDHS has good reliability and validity, suggesting that it is an appropriate instrument for evaluating learned helplessness in Chinese patients with chronic diseases. The Chinese version of the CDHS demonstrated good internal consistency and test-retest reliability for the total score and each dimension, consistent with the findings of the original author [20]. Previous studies on the localization of LH assessment tools for chronic disease patients have yielded comparable results. Thumboo et al. [32] adapted and cross-culturally validated the Chinese version of the Rheumatology Attitudes Index (CRAI) based on the Arthritis Helplessness Index (AHI), demonstrating good internal consistency (Cronbach’s α = 0.69–0.74) and test-retest reliability (ICC = 0.72–0.88) in 69 Chinese patients with systemic lupus erythematosus (SLE). Xie et al. [33] developed the LHS-MHD-C scale for Chinese hemodialysis patients based on the AHI and validated it in 1,202 Chinese hemodialysis patients, demonstrating satisfactory internal consistency (Cronbach’s α = 0.759) and test-retest reliability (ICC = 0.772). Quinless et al. [17] developed the 20-item Learned Helplessness Scale (LHS-20), which has been widely used in English-speaking countries. Lan et al. [34] translated and adapted the LHS-20, selecting 14 items to form the Chinese version of the LHS-14. This version demonstrated good internal consistency (Cronbach’s α = 0.79) and factor consistency (Cronbach’s α = 0.63–0.87) among law school students. Moreover, the LHS-18 developed by Wu et al. [18] has been extensively utilized to assess LH in various Chinese populations, including stroke patients, stoma patients, and ICU patients. This assessment tool has demonstrated good internal consistency and test-retest reliability in these groups. These findings indicate that LH assessment tools demonstrate high stability and consistency across different cultural contexts. Regarding the construct validity of the instrument, the Chinese version of the CDHS demonstrated satisfactory structural validity. Notably, The three-factor model demonstrated good fit in this study. Our validity analysis shows that the CDHS has good structural validity and high internal consistency. Thus, for scenarios where researchers or practitioners need to assess the overall status of the variable, the overall scale is recommended for use to obtain a concise and integrated measurement result. And each subscale of CDHS corresponds to a distinct dimension of the core construct, and each subscale also demonstrates good reliability and structural validity. Therefore, if the research objective focuses on exploring the differences, influencing factors, or predictive effects of specific dimensions, using the subscales will provide more targeted and detailed information. In summary, the choice between the overall scale and subscales should be determined by the specific research questions and practical needs. The criterion-related validity analysis demonstrated that LH in Chinese patients with chronic diseases exhibited a significant positive correlation with anxiety and depression and a negative correlation with self-efficacy. Scherer et al. [31] conducted a cross-sectional observational study of 59 patients with systemic lupus erythematosus and demonstrated a significant positive correlation between LH and anxiety levels. Similarly, Odero et al. [29], Nejla et al. [35], and Boysan et al. [36] reached analogous conclusions. A two-year longitudinal study also indicated that individuals with higher levels of helplessness were more likely to exhibit anxiety tendencies, suggesting a potential link between anxiety symptoms and LH. One potential explanation for this phenomenon is that anxiety-related emotional disorders and maladaptive coping mechanisms may increase patients’ sense of helplessness. Furthermore, a cross-sectional study by Smallheer et al. [28] demonstrated a significant positive correlation between depressive symptoms and LH scores. A prospective longitudinal study by Chen et al. [30] in China involving 236 participants revealed that individuals with a greater degree of helplessness were more likely to develop depressive tendencies or symptoms under stress. Negative thinking, a lack of motivation, and social withdrawal associated with depression can intensify the sense of helplessness. Consequently, individuals with elevated LH are at increased risk for anxiety and depressive symptoms. Timely assessment of LH can assist in the prevention of anxiety and depression comorbidities in patients with chronic diseases. Furthermore, our study revealed that patients with higher levels of helplessness often exhibited lower levels of self-efficacy. A study by Salomons et al. [37] involving 253 patients with chronic diseases revealed that learned helplessness could affect individuals’ self-management abilities, leading to a decrease in self-efficacy. A lack of self-efficacy may result in a reduction in confidence and the ability to cope with challenges, thereby increasing feelings of helplessness. This provides a promising avenue for future research aimed at improving learned helplessness in chronic disease patients. This study is subject to several limitations. Primarily, the sample size was relatively small, and the participants were drawn from economically developed regions of China, all from the same hospital, with the majority of samples coming from the rheumatology and immunology department. This may not fully reflect the psychological state of all chronic disease patients and lacks national representativeness. Future research should include larger and more representative samples to enhance the generalizability and broad applicability of the results. Second, the study did not include all potential factors that could influence helplessness in chronic disease patients, such as personality traits and social support. The role of these factors in the development of helplessness has not been fully explored. Future research should investigate these factors further to provide a more comprehensive understanding of the psychological state of chronic disease patients and to inform precise interventions for their helplessness. Conclusion The Chinese version of the CDHS was adapted and tested among Chinese chronic disease patients, and it was found to exhibit satisfactory psychometric properties. In this study, the Chinese version of the CDHS demonstrated excellent reliability and validity for the total scale and each dimension, presenting a three-factor structure with good fit indices. In summary, the 12-item Chinese version of the CDHS is a reliable tool for measuring learned helplessness in Chinese patients with chronic diseases. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 2 Acknowledgements We would like to express our gratitude to the staff at the affiliated hospital for their invaluable assistance in participant recruitment and data collection. Furthermore, we are indebted to our colleagues for their invaluable feedback throughout the course of the study. Abbreviations Body mass index Confirmatory Factor Analysis Chronic Disease Experience Survey Cognitive Dimension of Chronic Disease Helplessness Survey Emotional Dimension of Chronic Disease Helplessness Survey Motor Dimension of Chronic Disease Helplessness Survey Comparative Fit Index Exploratory Factor Analysis Generalized Anxiety Disorder Scale Intraclass correlation coefficient Learned Helplessness Learned Helplessness Scale-18 Numerical Rating Scale Patient Health Questionnaire-9 Root mean square error of approximation Self-Efficacy for Managing Chronic Disease 6-Item Scale Standardized root mean square residual Tucker‒Lewis Index World Health Organization Author contributions Huang Bingying: Conceptualization, Data curation, Methodology, Writing – original draft, Writing – review & editing. Jiaying Tang: supervision, project administration, methodology, writing – review & editing. Zhiting Guo: Data analysis, methodology. Ying Chen: Investigation, Data curation and Validation. Lili Zhou: Formal analysis and data collection. Fengying Zhang: Resources, Data collection. Qiaomei Zhao: Investigation, Data collection. Hua Zhao: Supervision, Project administration. Funding The author(s) declare that no financial support was provided for the research, authorship, or publication of this article. Data availability The datasets analyzed in this study are available in the article and supplementary materials. The corresponding author can be contacted if further information on the data are needed. Declarations Ethics approval and consent to participate This study was conducted in accordance with the tenets of the Declaration of Helsinki and in strict compliance with local laws. Informed consent was obtained from all participants before enrollment. The study protocol was approved by the Institutional Review Board of the Second Affiliated Hospital of Zhejiang University (approval number 2023 − 0664). Data confidentiality was strictly maintained throughout the study period to ensure the privacy and rights of all participants. Permission for the translation of the Chronic Disease Helplessness Survey (CDHS) and for the use of instruments requiring authorization (such as the LHS-18) was obtained from their respective original developers prior to the study. Other instruments used in this study (such as the GAD-7 and PHQ-9) are freely available in the public domain. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Jiaying Tang contributed equally to this work and shares first authorship. Contributor Information Jiaying Tang, Email: 157858@zju.edu.cn. Hua Zhao, Email: 2503125@zju.edu.cn. References Associated Data Supplementary Materials Supplementary Material 1 Supplementary Material 2 Data Availability Statement The datasets analyzed in this study are available in the article and supplementary materials. The corresponding author can be contacted if further information on the data are needed.